Genmab — November 2023
-
Genmab får barberet 500 kr. af sit kursmål hos Jefferies https://www.proinvestor.com/investornyt/1083119/genmab-far-barberet-500-kr-af-sit-kursmal-hos-jefferies
-
patient report- Cycle 4, Epcoritamab Trial for CLL / SLL https://cllsociety.org/2023/11/cycle-4-epcoritamab-trial-for-cll-sll/
-
Renten bliver normalt sænket meget hvis der er recession. En recession er jo tegn på økonomien går ad H til. Typisk vil en recession være årsagen til, at obligationskurserne stiger – og renterne falder meget – da det får centralbanken til at sænke renten og stimulere økonomien, mens investorerne søger sikker havn i statsobligationerne.
-
Novartis approximates Kesimpta Peak sales at $4bn in their investor presentation https://www.novartis.com/sites/novartiscom/files/novartis-investors-r-d-day-2023.pdf
Kunne være dejligt hvis det blev begrundet og motiveret hvorfor kursmålet ændres
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind